On January 18, 2023 IntraOp Medical Corporation reported that doctors at Vanderbilt University Medical Center (VUMC) treated a pancreatic cancer patient using IntraOp Mobetron Intra-Operative Radiation Therapy (IORT) (Press release, IntraOp Medical, JAN 18, 2023, View Source [SID1234626363]). Based in Nashville, Tennessee, and serving the southeast region of the United States, Vanderbilt University Medical Center is the only hospital in the state with this first-of-its-kind technology and the only Center of Excellence for pancreatic cancer as designated by the National Pancreas Foundation.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The procedure marks the first time VUMC — the largest comprehensive research, teaching and patient care health system in the Mid-South region — has utilized IORT with electrons in treating a patient with pancreatic cancer. The procedure was performed by surgical oncologist, Kamran Idrees, MD, MSCI, MMHC, FACS, and radiation oncologist, Natalie A Lockney, MD.
"We are encouraged by the results of the IORT with electrons in treating localized pancreatic cancer," said Dr. Kamran Idrees. "We serve our patients by implementing the latest innovations at Vanderbilt to improve outcomes."
Pancreatic cancer remains one of the deadliest forms of cancer. As the safest and most advanced portable LINAC available, the IntraOp Mobetron has established itself as an essential treatment tool for this most challenging indication. But it’s the precision of the device that makes it so effective. Due to the location of the pancreas and its proximity to major vessels, duodenum, spinal cord, stomach, small and large bowel, liver and kidneys makes precision critical. IORT with electrons makes precise surgery available for more patients than ever before.
"While this procedure is a first for the extraordinary team at Vanderbilt University Medical Center, it is yet another chapter for the promise of IORT with electrons and our collective fight to better treat pancreatic cancer," added Sanjay Arora, CEO at IntraOp. "We’re excited to see where this important milestone leads us."
About Vanderbilt University Medical Center
Vanderbilt University Medical Center is the largest comprehensive research, teaching and patient care health system in the Mid-South region, with the highest ranked adult and children’s hospitals in the Southeast by U.S. News & World Report. Based in Nashville, Tennessee, VUMC sees over 3 million patient visits per year in over 200 ambulatory locations, performs 88,000 surgical operations and discharges 75,000 inpatients from its main-campus adult, children’s, psychiatric and rehabilitation hospitals and three regional community hospitals. The Medical Center is the largest non-governmental employer of Middle Tennesseans, with nearly 40,000 staff, including more than 3,000 physicians, advanced practice nurses and scientists appointed to the Vanderbilt University faculty. For more information and the latest news follow VUMC on Facebook, LinkedIn, Twitter and in the VUMC Reporter.
Kamran Idrees, MD, MSCI, MMHC, FACS is an Associate Professor of Surgery, Ingram Associate Professor of Cancer Research, Chief, Division of Surgical Oncology & Endocrine Surgery, and Director, Pancreatic and GI Surgical Oncology. Natalie A Lockney, MD is an Assistant Professor in Radiation Oncology at Vanderbilt University Medical Center and the Program Director for the radiation oncology medical residency.